Catechol-O-methyltransferase inhibitors: new options for Parkinson's disease.
作者信息
Leicht M J, Mitchell S D
出版信息
S D J Med. 1999 Aug;52(8):295-7.
PMID:10453205
Abstract
摘要
相似文献
1
Catechol-O-methyltransferase inhibitors: new options for Parkinson's disease.
S D J Med. 1999 Aug;52(8):295-7.
2
Tolcapone for Parkinson's disease.托卡朋用于治疗帕金森病。
Med Lett Drugs Ther. 1998 Jun 5;40(1028):60-1.
3
[COMT inhibitors].[儿茶酚-O-甲基转移酶抑制剂]
Med Monatsschr Pharm. 1999 May;22(5):138-41.
4
[COMT inhibition with tolcapone].[托卡朋抑制儿茶酚-O-甲基转移酶]
Nervenarzt. 1996 Jul;67(7 Suppl Comt-hemmu):1-8.
5
COMT inhibition and safety.儿茶酚-O-甲基转移酶抑制作用与安全性。
Funct Neurol. 2001;16(4 Suppl):135-40.
6
Catechol-O-methyltransferase inhibitors in Parkinson's disease.
Lancet. 1998 Jun 27;351(9120):1965-6. doi: 10.1016/s0140-6736(05)78659-1.
7
COMT inhibition in Parkinson's disease: rationale and clinical relevance.
Acta Neurol Belg. 2000 Mar;100(1):5-7.
8
COMT inhibitors: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S45-51. doi: 10.1002/mds.5560.
9
[Treatment in Parkinson disease].[帕金森病的治疗]
Orv Hetil. 2004 Apr 11;145(15):833-4.
10
New options for treatment of Parkinson's disease.帕金森病治疗的新选择。
Baillieres Clin Neurol. 1997 Apr;6(1):109-23.
Zotero 插件